Working... Menu

Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy (BTXADMPPNP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02460107
Recruitment Status : Terminated (Enrolling failure (lack of participants))
First Posted : June 2, 2015
Last Update Posted : August 8, 2017
Information provided by (Responsible Party):
Myung Eun Chung, MD, PhD, Catholic University of Korea Saint Paul's Hospital

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 30, 2016
  Actual Study Completion Date : December 31, 2016